Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
QuintilesIMS
Federal Trade Commission
Colorcon
Cipla

Generated: March 26, 2019

DrugPatentWatch Database Preview

Sun Pharma Global Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARMA GLOBAL, and when can generic versions of SUN PHARMA GLOBAL drugs launch?

SUN PHARMA GLOBAL has eighty-two approved drugs.

There are eight US patents protecting SUN PHARMA GLOBAL drugs. There are eight tentative approvals on SUN PHARMA GLOBAL drugs.

There are one hundred and sixty-one patent family members on SUN PHARMA GLOBAL drugs in forty-nine countries and two hundred supplementary protection certificates in fourteen countries.

Summary for Sun Pharma Global
International Patents:161
US Patents:8
Tradenames:72
Ingredients:71
NDAs:82
Patent Litigation for Sun Pharma Global: See patent lawsuits for Sun Pharma Global

Drugs and US Patents for Sun Pharma Global

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 078805-001 Apr 21, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 201190-001 Mar 27, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global MEMANTINE HYDROCHLORIDE memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205905-004 Sep 28, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 200484-002 Apr 23, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077926-002 Sep 19, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 203059-001 Sep 9, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 205618-001 Apr 6, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for SUN PHARMA GLOBAL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 125 mg ➤ Subscribe 2018-07-23

International Patents for Sun Pharma Global Drugs

Country Patent Number Estimated Expiration
Taiwan I367883 ➤ Try a Free Trial
Japan 2011508724 ➤ Try a Free Trial
Georgia, Republic of P20125592 ➤ Try a Free Trial
New Zealand 572362 ➤ Try a Free Trial
China 101437800 ➤ Try a Free Trial
Australia 2014232508 ➤ Try a Free Trial
Norway 20085059 ➤ Try a Free Trial
Country Patent Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Sun Pharma Global Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1412357 PA2008013,C1412357 Lithuania ➤ Try a Free Trial PRODUCT NAME: SITAGLIPTINUM PHOSPHAS MONOHYDRICUS, METFORMINI HYDROCHLORIDUM; REGISTRATION NO/DATE: EU/1/08/455/001 - EU/1/08/455/014 20080716
1534313 92923 Luxembourg ➤ Try a Free Trial PRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
0473687 SPC/GB98/030 United Kingdom ➤ Try a Free Trial PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204
0236684 C300140 Netherlands ➤ Try a Free Trial PRODUCT NAME: GALANTAMINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER GALANTAMINE HYDROBROMIDE; NAT. REGISTRATION NO/DATE: RVG 29073 - RVG 29076 20030702; FIRST REGISTRATION: SE 15561 - 15565 20000225
1532149 CA 2013 00001 Denmark ➤ Try a Free Trial PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3,7-DIHYDROPURIN-2,6-DION ENANTIOMERER OG SALTE DERAF - SAERLIGT LINAGLIPTIN - I KOMBINATION MED METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/12/780/001-028 20120720
2316456 2017C/064 Belgium ➤ Try a Free Trial PRODUCT NAME: NALTREXONE/BUPROPION; AUTHORISATION NUMBER AND DATE: EU/1/14/988 20150330
0058146 2001C/045 Belgium ➤ Try a Free Trial PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Medtronic
US Department of Justice
Daiichi Sankyo
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.